SANDLER LAURA LEE (Chief Operating Officer) sold 6.0% of their position (13K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $370.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/2/2026ACC: 0000907654-26-000002
Officer· Chief Operating Officer
Since Mar 2026
-13K
Net shares
Net seller
$370.8K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
5K acquired · 18K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5K
Price / share
$7.80
Trade value
$39K
% of position
2.3%
1/2/2026
213.08K→218.08K
Common Stock
Direct
Shares
−8.75K
Price / share
$28.17
Trade value
$246.40K
% of position
4.0%
1/2/2026
218.08K→209.34K
Common Stock
Direct
Shares
−3.14K
Price / share
$29.08
Trade value
$91.43K
% of position
1.5%
1/2/2026
209.34K→206.19K
Common Stock
Direct
Shares
−1.11K
Price / share
$29.75
Trade value
$32.97K
% of position
0.5%
1/2/2026
206.19K→205.08K
Total
Net shares
−8K
Net value
-$331.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +5K | $7.80 | $39K | 2.3% | 213.08K | 218.08K |
| Common Stock Direct | 1/2/2026 | S · Sale | −8.75K | $28.17 | $246.40K | 4.0% | 218.08K | 209.34K |
| Common Stock Direct | 1/2/2026 | S · Sale | −3.14K | $29.08 | $91.43K | 1.5% | 209.34K | 206.19K |
| Common Stock Direct | 1/2/2026 | S · Sale | −1.11K | $29.75 | $32.97K | 0.5% | 206.19K | 205.08K |
| Total | −8K | -$331.80K | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
7.80
Held after
95K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock5K shares | 1/2/2026 | M · Option Exercise | −5K | 7.80 | — | 95K |